About Us

Advancing cancer care for more than 25 years

Aptium Oncology pioneered the concept of comprehensive outpatient cancer care in 1983. The business evolved from the vision of a nephrologists who operated a successful network of outpatient dialysis care under the name Salick Health Care. The fragmentation of the conventional cancer care prompted him to design a cancer treatment program that brought all core cancer services under one roof, and thus was the first comprehensive outpatient cancer center at Cedars-Sinai Medical Center in Los Angeles, operating under the hospital's name and aegis with a management contract. The center, which opened in 1985, offered around-the-clock services including medical oncology, radiation oncology, psycho-social support services and amenities such as VCRs and valet parking.

The company went public that year and began adding facilities. Zeneca (now AstraZeneca) bought half of Salick Health Care in 1995, and completed their purchase in 1997. While Aptium Oncology is a subsidiary of the AstraZeneca, the company is highly distinct in that it is solely focused on the dispensation of cancer care and is not involved in the manufacture of cancer drugs. In 2001, Aptium began a consulting division to provide oncology business and clinical planning support to hospitals. The Company has served over 30 clients nationally.